NASDAQ:CDNA
CareDx Stock News
$15.63
+0.130 (+0.84%)
At Close: May 20, 2024
CareDx Showcases Transplantation Innovation and Leadership in Europe at EFI 2021
07:00am, Tuesday, 20'th Apr 2021
Virtual Events to Highlight New Data and AlloSeq Solutions for European Labs and Clinicians Virtual Events to Highlight New Data and AlloSeq Solutions for European Labs and Clinicians
CareDx to Present at UNOS Transplant Management Forum
07:00am, Friday, 16'th Apr 2021
Company to showcase its latest integrated solutions for improving care across the whole transplant journey Company to showcase its latest integrated solutions for improving care across the whole trans
CareDx Announces New HLA Typing Service Offering for Research Purposes
07:00am, Thursday, 08'th Apr 2021
Initial projects underway for global pharmaceutical company Initial projects underway for global pharmaceutical company
CareDx to Participate in National Kidney Foundation 2021 Spring Clinical Meetings
07:00am, Monday, 05'th Apr 2021
CareDx to Host Virtual Exhibitor Showcase and Continuing Medical Education Program CareDx to Host Virtual Exhibitor Showcase and Continuing Medical Education Program
CareDx Enhances Leadership Team with Key Appointments
07:00am, Wednesday, 31'st Mar 2021
CareDx Builds for the Future by Investing in Talent CareDx Builds for the Future by Investing in Talent
CareDx Names Ankur Dhingra as New Chief Financial Officer
04:05pm, Thursday, 11'th Mar 2021
SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clini
Like Guardant Health? You'll Love CareDx
08:17am, Wednesday, 03'rd Mar 2021
This under-the-radar diagnostics company is thriving yet reasonably priced.
CareDx, Inc. (CDNA) CEO Reginald Seeto on Q4 2020 Results - Earnings Call Transcript
10:38pm, Wednesday, 24'th Feb 2021
CareDx, Inc. (CDNA) CEO Reginald Seeto on Q4 2020 Results - Earnings Call Transcript
CareDx Reports Fourth Quarter and Full Year 2020 Results
04:01pm, Wednesday, 24'th Feb 2021
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinica
CareDx (CDNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
01:42pm, Wednesday, 17'th Feb 2021
CareDx (CDNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CareDx to Report Fourth Quarter and Full Year 2020 Financial Results
07:00am, Friday, 12'th Feb 2021
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinic
CareDx to to Participate in Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
07:00am, Wednesday, 10'th Feb 2021
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinica
CareDx Showcases Cellular Transplantation and Therapy Portfolio at TCT
07:00am, Friday, 05'th Feb 2021
CareDx and Atara Biotherapeutics' AlloCell Partnership Highlighted in Poster Presentation at Upcoming TCT Meeting CareDx and Atara Biotherapeutics' AlloCell Partnership Highlighted in Poster Presentat
CareDx Announces Closing of Public Offering of Common Stock
04:28pm, Monday, 25'th Jan 2021
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinica
CareDx Announces Pricing of Public Offering of Common Stock
10:56pm, Wednesday, 20'th Jan 2021
SOUTH SAN FRANCISCO, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinica
